These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2086018)

  • 1. [Effect of fluoroquinolones made in China in the treatment of acute bacillary dysentery. A report of 212 cases].
    Wang XF; Jiang SC; Wei YL
    Zhonghua Nei Ke Za Zhi; 1990 Aug; 29(8):482-4, 511. PubMed ID: 2086018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of enoxacin].
    Zhang YY; Zhun BY; Jiang SC
    Zhonghua Nei Ke Za Zhi; 1991 Aug; 30(8):480-3, 521. PubMed ID: 1794242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics and clinical studies of norfloxacin in the pediatric field].
    Motohiro T; Yoshinaga Y; Tsumura N; Oki S; Sasaki H; Aramaki M; Oda K; Kawakami A; Koga T; Shimada Y
    Jpn J Antibiot; 1990 May; 43(5):901-17. PubMed ID: 2202843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of fluoroquinolones (norfloxacin, enoxacin, ofloxacin) in the therapy of lower urinary tract infections].
    Tizzani A; Casetta G; Cavallini A; Piana P
    Minerva Urol Nefrol; 1990; 42(2):81-4. PubMed ID: 2392745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic resistance of shigellae and rationale for etiotropic therapy of Shigella infections].
    Galushko NA; D'iachenko AG; Chemich ND; D'iachenko PA
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (2):71-5. PubMed ID: 15881945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
    Bhattacharya MK; Nair GB; Sen D; Paul M; Debnath A; Nag A; Dutta D; Dutta P; Pal SC; Bhattacharya SK
    J Diarrhoeal Dis Res; 1992 Sep; 10(3):146-50. PubMed ID: 1430968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimethoprim-sulfamethoxazole compared to ampicillin in the treatment of shigellosis.
    Chang MJ; Dunkle LM; Van Reken D; Anderson D; Wong ML; Feigin RD
    Pediatrics; 1977 May; 59(5):726-9. PubMed ID: 323811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia.
    Panhotra BR; Saxena AK; Al-Mulhim K
    Jpn J Infect Dis; 2004 Jun; 57(3):116-8. PubMed ID: 15218222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of CTX-M-14 extended-spectrum beta-lactamase in Shigella sonnei isolates from China.
    Xiong Z; Li T; Xu Y; Li J
    J Infect; 2007 Nov; 55(5):e125-8. PubMed ID: 17767959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.
    De Mol P; Mets T; Lagasse R; Vandepitte J; Mutwewingabo A; Butzler JP
    J Antimicrob Chemother; 1987 May; 19(5):695-8. PubMed ID: 3301783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unusual hallucination with norfloxacin.
    Rataboli PV; D'Souza RS; Dhume VG
    J Assoc Physicians India; 1996 Jul; 44(7):504. PubMed ID: 9282621
    [No Abstract]   [Full Text] [Related]  

  • 12. [Shigellosis in children of the IX region of Chile: clinical and epidemiologic aspects and antibiotic sensitivity].
    Boehme C; Rodríguez G; Illesca V; Reydet P; Serra J
    Rev Med Chil; 1992 Nov; 120(11):1261-6. PubMed ID: 1340946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial of ampicillin v. trimethoprim-sulphamethoxazole in the treatment of Shigella dysentery.
    Yunus M; Mizanur Rahman AS; Farooque AS; Glass RI
    J Trop Med Hyg; 1982 Oct; 85(5):195-9. PubMed ID: 6757458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Observation of 212 cases of typhoid fever treated with FQNS].
    Jiang S; Wang X; Feng S
    Zhonghua Yi Xue Za Zhi; 1997 May; 77(5):336-9. PubMed ID: 9772486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children.
    Bhattacharya K; Bhattacharya MK; Dutta D; Dutta S; Deb M; Deb A; Das KP; Koley H; Nair GB
    Acta Paediatr; 1997 Mar; 86(3):319-20. PubMed ID: 9099325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of enoxacin and norfloxacin in patients with cystitis.
    Yamamoto M; Nagai T; Takaba H; Hashimoto J; Miyake K
    Hinyokika Kiyo; 1987 Dec; 33(12):2141-4. PubMed ID: 3482344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of Shigella sonnei strains in dysentery epidemic in the province of Szczecin].
    Swiderski M
    Pediatr Pol; 1982; 57(7-8):511-6. PubMed ID: 6763189
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.
    Rogerie F; Ott D; Vandepitte J; Verbist L; Lemmens P; Habiyaremye I
    Antimicrob Agents Chemother; 1986 May; 29(5):883-6. PubMed ID: 3524434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Antibiotic susceptibility of Shigella in Australia.
    Thomas E; Kostalas G; Beare JH
    Lancet; 1974 May; 1(7863):936. PubMed ID: 4133465
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of antibioticoresistant colibacterin during treatment of dysentery Sonnei].
    Bogdanov IL; Goliusova EV; Bass TM; Ozerianskaia NM; Golovko IA
    Vrach Delo; 1974 Jun; (6):146-7. PubMed ID: 4619244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.